Apimeds Pharmaceuticals US (APUS) Retained Earnings (2023 - 2025)
Apimeds Pharmaceuticals US (APUS) posted Retained Earnings of -$10.4 million for Q4 2025, down 12.51% on a QoQ basis from -$9.2 million in Q3 2025, and down 136.64% year-over-year from $28.4 million in Q4 2024.
Apimeds Pharmaceuticals US (APUS) Retained Earnings (2023 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US's Retained Earnings history runs 3 years deep, the most recent figure standing at -$10.4 million for Q4 2025.
- Quarterly Retained Earnings fell 136.64% year-over-year to -$10.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$10.4 million (down 136.64% YoY) and the FY2025 annual result came in at -$10.4 million, down 136.64% from the prior year.
- Retained Earnings was -$10.4 million for Q4 2025 at Apimeds Pharmaceuticals US, down from -$9.2 million in the prior quarter.
- Across five years, Retained Earnings topped out at $3.0 million in Q4 2023 and bottomed at -$10.4 million in Q4 2025.
- A 3-year average of -$5.6 million and a median of -$6.1 million in 2025 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings slumped 248.64% — and 2025, when it slumped 136.64%.
- Apimeds Pharmaceuticals US's Retained Earnings stood at $3.0 million in 2023, then slumped by 248.64% to -$4.4 million in 2024, then slumped by 136.64% to -$10.4 million in 2025.
- Business Quant data shows APUS's Retained Earnings at -$10.4 million in Q4 2025, -$9.2 million in Q3 2025, and -$7.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Apimeds Pharmaceuticals US | 8.17 Mn | 8.17 Mn | - | -10.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.39 Mn |
| Sep 30, 2025 | -9.24 Mn |
| Jun 30, 2025 | -7.46 Mn |
| Mar 31, 2025 | -4.79 Mn |
| Dec 31, 2024 | -4.39 Mn |
| Dec 31, 2023 | 2.95 Mn |